Skip to main content
main-content

Onkologie und Hämatologie | Zeitschrift

memo - Magazine of European Medical Oncology 4/2019
memo - Magazine of European Medical Oncology

Ausgabe 4/2019

share
TEILEN
insite
SUCHEN

Inhaltsverzeichnis (19 Artikel)

01.12.2019 | editorial

An update from the 2019 ASCO Annual Meeting
Rupert Bartsch

01.12.2019 | editorial

Amazing advances in the field of uro-oncology
Dora Niedersüß-Beke

01.12.2019 | editorial

Optimizing care for geriatric cancer patients: the greatest challenge in medical oncology?
Rupert Bartsch

Open Access 06.11.2019 | original report

Prevalence of comorbidity in cancer patients scheduled for systemic anticancer treatment in Austria
A cross-sectional multicentre observational study
Assoc. Prof. Marija Balic MDPhD, Wolfgang Hilbe, Sylvia Gusel, Michael Fiegl, Heinz Ludwig, Beate Mayrbäurl, Josef Thaler, Hellmut Samonigg, Karin Hegenbarth, Florian Eisner, Brigitte Mlineritsch, Richard Greil, Maria Johanna Schandl, Ansgar Weltermann, Andreas Petzer, David Fuchs, Wolfgang Stangl, Peter Krippl, Reinhard Stauder, Herbert Stöger

06.11.2019 | short review

Current trends in small cell lung cancer management—ASCO 2019 update
Mircea Dediu MD, PhD

Open Access 06.11.2019 | short review

Targeted therapy in lung cancer—ASCO 2019 update
Romana E. Wass M.D., Ph.D., David Lang M.D., Bernd Lamprecht M.D., Michael Studnicka M.D.

21.11.2019 | short review

ASCO 2019—Personal highlights on adjuvant breast cancer: (neo-)adjuvant therapy of HER2-negative HR-positive BC
Prof. Semir Beslija MD, PhD

Open Access 12.11.2019 | review

ASCO 2019: highlights in HER2-positive metastatic breast cancer
Rupert Bartsch, Elisabeth Bergen

Open Access 15.10.2019 | short review

Adjuvant breast cancer: (neo)adjuvant therapy for HER2-positive breast cancer
The best of ASCO 2019
Christoph Suppan, Marija Balic

14.11.2019 | short review

Management of nonmetastatic muscle invasive bladder cancer in the elderly
Prof. Stephan Madersbacher MD, FEBU

Open Access 27.09.2019 | short review

Nonmuscle invasive urothelial cancer— Bacillus Calmette–Guérin instillation or checkpoint inhibitor immunotherapy?
Stephan Brönimann, Shahrokh F. Shariat, Melanie R. Hassler

28.10.2019 | short review

Advanced/metastatic urothelial carcinoma of the bladder and upper urinary tract
Presentation highlights from the ASCO 2019 Congress
Assoc. Prof. Georg C. Hutterer MD, Assoc. Prof. Martin Pichler MD

Open Access 23.10.2019 | short review

Neoadjuvant therapy in urothelial cancer
New therapies on the horizon
Stephan Brönimann, David D’Andrea, Shahrokh F. Shariat, Kilian M. Gust MD

21.11.2019 | short review

First-line treatment of metastatic renal cell carcinoma: current standard of care
Assoc. Prof. Martin Marszalek MD

14.11.2019 | short review

Second-line therapy in metastatic renal cell cancer—how do we treat after immuno-oncology drugs?
Ursula Vogl MD

28.11.2019 | short review

Biomarkers in renal cell carcinoma
OÄ. Dr. Jasmin Terzic, Univ.-Prof. Dr. med. univ. Thomas Bauernhofer

21.11.2019 | short review

Surgery in renal cell carcinoma—when, whom and how?
Sebastian Lenart MD, Ingrid Berger, Nikolaus Hartig, Stephan Madersbacher, Anton Ponholzer

Open Access 27.11.2019 | short review

HPV-associated cancers
Dr. Christoph Minichsdorfer PhD

26.06.2019 | case report

Giant leiomyoma of the renal capsule: CT and MR imaging features with pathologic correlations
Arnaldo Stanzione, Michele Santangelo, Filippo De Rosa, Andrea Ponsiglione, Gaia Peluso, Luigi Insabato, Massimo Imbriaco MD